IGM Biosciences, Inc.

NasdaqGS:IGMS 株式レポート

時価総額:US$528.6m

IGM Biosciences マネジメント

マネジメント 基準チェック /24

IGM Biosciencesの CEO はMary Harlerで、 Oct2024年に任命され、 の在任期間は 1 年未満です。 は、会社の株式の0.59%を直接所有しており、その価値は$ 3.10M 。経営陣と取締役会の平均在任期間はそれぞれ3年と6年です。

主要情報

Mary Harler

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権0.6%
経営陣の平均在職期間3yrs
取締役会の平均在任期間6yrs

経営陣の近況

Recent updates

We're Not Very Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

Oct 08
We're Not Very Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

IGM Biosciences: Waiting For Godot

Sep 18

IGM Biosciences: Unlikely To Move The Needle Again In 2024

May 12

Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?

Apr 28
Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?

IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points

Feb 12

We Think IGM Biosciences (NASDAQ:IGMS) Needs To Drive Business Growth Carefully

Nov 20
We Think IGM Biosciences (NASDAQ:IGMS) Needs To Drive Business Growth Carefully

We're Not Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn

May 10
We're Not Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn

Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

Jan 05
Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

IGM Biosciences (NASDAQ:IGMS) Is In A Strong Position To Grow Its Business

Sep 23
IGM Biosciences (NASDAQ:IGMS) Is In A Strong Position To Grow Its Business

IGM Biosciences started at BofA Securities with a buy on IgM antibody candidates

Aug 29

IGM Biosciences GAAP EPS of -$1.33 misses by $0.93, revenue of $0.4M

Aug 08

We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

Jun 09
We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

IGM Biosciences: Interesting Science, Poor Trial Data

Feb 23

Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Deliver On Growth Plans?

Feb 17
Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

Sep 07
Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

May 25
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

CEO(最高経営責任者

Mary Harler (59 yo)

less than a year

在職期間

Ms. Mary Beth Harler, M.D. is the Chief Executive Officer of IGM Biosciences, Inc. since October 01, 2024 and serves as its Director. She had been Head of Research & Autoimmunity at IGM Biosciences, Inc. s...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Mary Harler
CEO & Directorless than a yearデータなし0.59%
$ 3.1m
Misbah Tahir
Chief Financial Officer5.8yrsUS$1.08m0.035%
$ 186.3k
TS Harigopal
Senior Vice President of Group Operations1.8yrsデータなしデータなし
Steven Weber
Senior VP2.7yrsデータなし0.0043%
$ 22.9k
Paul Graffagnino
Senior Vice President of Legal Affairs3.8yrsデータなしデータなし
Suzette Tauber
Chief Human Resources Officer5.4yrsデータなしデータなし
Angus Sinclair
Executive Vice President of Research3.3yrsデータなしデータなし
Lisa Decker
Chief Business Officer3.7yrsUS$4.92m0.030%
$ 160.1k
Marvin Peterson
Executive Vice President of Process Development & Manufacturing3.6yrsデータなしデータなし
Elizabeth Haanes
Senior Vice President of Intellectual Property2.6yrsデータなしデータなし
Elaine Sapinoso
Senior Vice President of Quality1.8yrsデータなしデータなし
Faraz Siddiqui
Senior Vice President of Manufacturing Operations1.3yrsデータなしデータなし

3.0yrs

平均在職期間

55yo

平均年齢

経験豊富な経営陣: IGMSの経営陣は 経験豊富 であると考えられます ( 3年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Mary Harler
CEO & Directorno dataデータなし0.59%
$ 3.1m
Felix Baker
Independent Director3.8yrsUS$168.55k0.0037%
$ 19.7k
M. Behrens
Independent Director5.8yrsUS$178.30k0.68%
$ 3.6m
Mark Davis
Member of Scientific Advisory Boardno dataデータなしデータなし
Rafi Ahmed
Member of Scientific Advisory Boardno dataデータなしデータなし
Michael Lee
Independent Director5.3yrsUS$166.09k0.016%
$ 82.9k
Jakob Topsoe
Independent Director6.3yrsUS$166.09k0.15%
$ 785.2k
Julie Hambleton
Independent Director6.3yrsUS$204.09k0.0034%
$ 17.8k
Christina Topsoe
Independent Director6.3yrsUS$175.84k0.099%
$ 522.6k
William Strohl
Independent Director6.3yrsUS$236.59k0%
$ 0
Elizabeth Thompson
Independent Director1.1yrsUS$167.54k0.0073%
$ 38.7k
Gordon J. Freeman
Member of Scientific Advisory Boardno dataデータなしデータなし

6.0yrs

平均在職期間

55yo

平均年齢

経験豊富なボード: IGMSの 取締役会経験豊富 であると考えられます ( 6年の平均在任期間)。